CELZ Stock Analysis: Buy, Sell, or Hold?
CELZ - Creative Medical Technology Holdings, Inc. Common Stock
$1.42
0.27 (23.48%)
▲
5d:
+113.86%
30d:
+50.86%
90d:
-37.99%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 14, 2026
6d
Get Alerted When CELZ Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CELZ is 25.7% above its trading range ($1.13). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CELZ is 25.7% above its trading range ($1.13). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CELZ is currently trading at $1.42, which is considered extended relative to its 30-day fair value range of $0.70 to $1.13.
Technical Outlook: Technically, CELZ is in a strong downtrend. Immediate support is located at $0.62, while resistance sits at $1.94. The stock is showing strong short-term momentum, up 23.5% recently.
Market Sentiment: CELZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+1639.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CELZ is in a strong downtrend. Immediate support is located at $0.62, while resistance sits at $1.94. The stock is showing strong short-term momentum, up 23.5% recently.
Market Sentiment: CELZ has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $20.00 (+1639.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.70 -
$1.13
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+25.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+23.5%)
- BULLISH: Trading 1639.1% below Wall St target ($20.00)
- WARNING: Recommendation downgraded due to 25.7% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.70 -
$1.13
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.62
Resistance Level
$1.94
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.34
Wall Street Target
$20.00
(+1639.1%)
Earnings Growth (YoY)
358.9%
Share & Embed Analysis
Last updated: August 07, 2026 4:08 PM ET
Data refreshes hourly during market hours. Next update: 5:08 PM
Data refreshes hourly during market hours. Next update: 5:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELZ showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 55 HOLD |
